标题
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-11
DOI
10.3389/fendo.2022.800995
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
- (2019) Shidong Lv et al. BMC CANCER
- Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC
- (2019) Vincenza Ciaramella et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Thiazolidinediones as antidiabetic agents: A critical review
- (2018) M.J. Nanjan et al. BIOORGANIC CHEMISTRY
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- (2018) Angeliki M. Stamatouli et al. DIABETES
- Diabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’
- (2018) Angelo Cignarelli et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The administration of peroxisome proliferator-activated receptors α/γ agonist TZD18 inhibits cell growth and induces apoptosis in human gastric cancer cell lines
- (2018) Xichao Xia et al. Journal of Cancer Research and Therapeutics
- Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus
- (2018) Woo Sik Yu et al. JOURNAL OF SURGICAL ONCOLOGY
- The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma
- (2017) Emma S Scott et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway
- (2017) Masanobu Tsubaki et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes
- (2017) Jennifer W. Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE
- (2017) Susan Cornell JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Association of diabetes mellitus with thyroid cancer risk
- (2017) Hongtao Li et al. MEDICINE
- Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
- (2016) Bendix Carstensen et al. DIABETOLOGIA
- Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
- (2016) Lars Hofmann et al. EUROPEAN JOURNAL OF CANCER
- Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
- (2016) Roongruedee Chaiteerakij et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between markers of glucose metabolism and risk of colorectal cancer
- (2016) Jinming Xu et al. BMJ Open
- Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review
- (2016) Yuehong Chen et al. Journal of Diabetes
- Warburg Effect - a Consequence or the Cause of Carcinogenesis?
- (2016) Slobodan Devic Journal of Cancer
- The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration
- (2016) Linda A. Villani et al. Molecular Metabolism
- Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
- (2015) Mahnaz Mellati et al. DIABETES CARE
- mTOR inhibitors and diabetes
- (2015) Bruno Vergès et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms
- (2015) T. Byers et al. ENDOCRINE-RELATED CANCER
- The Development of Fulminant Type 1 Diabetes during Chemotherapy for Rectal Cancer
- (2015) Junichiro Adachi et al. INTERNAL MEDICINE
- State-of-the-art acute and chronic GVHD treatment
- (2015) Muhammad Omer Jamil et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: A meta-analysis of observational studies
- (2015) Yuhua Gong et al. ORAL ONCOLOGY
- Functional expression of sodium-glucose transporters in cancer
- (2015) Claudio Scafoglio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells
- (2015) Carminia Maria Della Corte et al. Oncotarget
- Diabetes mellitus and the risk of glioma: a meta-analysis
- (2015) Luqian Zhao et al. Oncotarget
- Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies
- (2015) Lang Wu et al. Scientific Reports
- Risk of bladder cancer in patients with diabetes: a retrospective cohort study
- (2015) M. E. Goossens et al. BMJ Open
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
- (2015) Agata Ptaszynska et al. Diabetes Therapy
- Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
- (2015) Agata Ptaszynska et al. Diabetes Therapy
- Does cancer risk increase with HbA1c, independent of diabetes?
- (2014) J C de Beer et al. BRITISH JOURNAL OF CANCER
- Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
- (2014) Jessica L. Harding et al. DIABETES CARE
- Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
- (2014) Pan Jian Gang et al. ENDOCRINE RESEARCH
- Diabetes mellitus and risk of prostate cancer in the EuropeanProspectiveInvestigation into Cancer and Nutrition
- (2014) Konstantinos K. Tsilidis et al. INTERNATIONAL JOURNAL OF CANCER
- Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
- (2014) Maximilian Kleinert et al. Molecular Metabolism
- Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
- (2013) Matteo Monami et al. ACTA DIABETOLOGICA
- Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies
- (2013) ANNALS OF INTERNAL MEDICINE
- Diabetes Mellitus and Prostate Cancer Risk in Asian Countries: a Meta-analysis
- (2013) Xiang-Ju Long et al. Asian Pacific Journal of Cancer Prevention
- Metformin in lung cancer: rationale for a combination therapy
- (2013) Floriana Morgillo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New insights into pancreatic cancer-induced paraneoplastic diabetes
- (2013) Raghuwansh P. Sah et al. Nature Reviews Gastroenterology & Hepatology
- The effect of metformin and thiazolidinedione use on lung cancer in diabetics
- (2012) Peter J Mazzone et al. BMC CANCER
- Diabetes and breast cancer risk: a meta-analysis
- (2012) P Boyle et al. BRITISH JOURNAL OF CANCER
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults
- (2012) P. T. Campbell et al. DIABETES CARE
- Insulin and its analogues and their affinities for the IGF1 receptor
- (2012) Aimee J Varewijck et al. ENDOCRINE-RELATED CANCER
- Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice
- (2012) Gaurav Aggarwal et al. GASTROENTEROLOGY
- Do Corticosteroids Provide Analgesic Effects in Cancer Patients? A Systematic Literature Review
- (2012) Ørnulf Paulsen et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
- (2012) Julien Diana et al. NATURE MEDICINE
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells
- (2012) N Heidari et al. Cell Death & Disease
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
- (2011) Brandon L. Pierce et al. CANCER CAUSES & CONTROL
- Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells
- (2011) Margot M.L. Linssen et al. CELLULAR SIGNALLING
- Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)
- (2011) N. Ewald et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Cancer occurrence in Danish diabetic patients: duration and insulin effects
- (2011) B. Carstensen et al. DIABETOLOGIA
- Insulin-Induced Oxidative Stress Up-Regulates Heme Oxygenase-1 via Diverse Signaling Cascades in the C2 Skeletal Myoblast Cell Line
- (2011) Ioanna-Katerina Aggeli et al. ENDOCRINOLOGY
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
- (2011) Qiwen Ben et al. EUROPEAN JOURNAL OF CANCER
- Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
- (2011) Ying Jiang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic susceptibility to pancreatic cancer
- (2011) Alison P. Klein MOLECULAR CARCINOGENESIS
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Genes Related to Diabetes May Be Associated With Pancreatic Cancer in a Population-Based Case-Control Study in Minnesota
- (2011) Anna E. Prizment et al. PANCREAS
- Pancreatogenic Diabetes: Special Considerations for Management
- (2011) YunFeng Cui et al. PANCREATOLOGY
- High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR
- (2011) Liang Han et al. PLoS One
- Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes
- (2010) A. M. Secrest et al. DIABETES
- Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden
- (2010) X. Shu et al. DIABETIC MEDICINE
- Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
- (2010) L. Sciacca et al. DIABETOLOGIA
- Risk of cancer in a large cohort of U.S. veterans with diabetes
- (2010) Elizabeth A. Atchison et al. INTERNATIONAL JOURNAL OF CANCER
- Adipokine regulation of colon cancer: Adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3
- (2010) Jenifer I. Fenton et al. MOLECULAR CARCINOGENESIS
- Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
- (2010) Mary Parks et al. NEW ENGLAND JOURNAL OF MEDICINE
- The proliferating role of insulin and insulin-like growth factors in cancer
- (2010) Emily Jane Gallagher et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development
- (2009) W.-Y. Kim et al. CANCER RESEARCH
- Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer
- (2009) Gina Lee et al. CURRENT OPINION IN PULMONARY MEDICINE
- Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes: Interactions With Metformin
- (2009) A. V. Matveyenko et al. DIABETES
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
- (2009) A. E. Butler et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
- (2009) D. H. van Raalte et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies
- (2009) Wensen Chen et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
- (2009) Louis J Sparvero et al. Journal of Translational Medicine
- Cancer Incidence and Mortality After Gastric Bypass Surgery
- (2009) Ted D. Adams et al. Obesity
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Sulphonylureas and cancer: a case–control study
- (2008) Matteo Monami et al. ACTA DIABETOLOGICA
- Mechanism and Management of AKT Inhibitor-Induced Hyperglycemia
- (2008) M.-C. Crouthamel et al. CLINICAL CANCER RESEARCH
- AGE-RAGE System and Carcinogenesis
- (2008) Riichiro Abe et al. CURRENT PHARMACEUTICAL DESIGN
- mTOR Inhibition by Rapamycin Prevents -Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes
- (2008) M. Fraenkel et al. DIABETES
- Cause-specific mortality in insulin-treated diabetic patients: A 20-year follow-up
- (2008) Shelagh I. Dawson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A genetic link between type 2 diabetes and prostate cancer
- (2008) T. M. Frayling et al. DIABETOLOGIA
- Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
- (2008) Rahul Pannala et al. GASTROENTEROLOGY
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
- (2008) Bethany B. Barone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma
- (2008) Martha Q. Lacy et al. JOURNAL OF CLINICAL ONCOLOGY
- Bariatric surgery reduces cancer risk in morbidly obese patients
- (2008) Nicolas V. Christou et al. Surgery for Obesity and Related Diseases
- The role of insulin receptors and IGF-I receptors in cancer and other diseases
- (2008) Francesco Frasca et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started